These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32726653)

  • 1. Sustained-release buprenorphine induces acute opioid tolerance in the mouse.
    Larson CM; Peterson CD; Kitto KF; Wilcox GL; Fairbanks CA
    Eur J Pharmacol; 2020 Oct; 885():173330. PubMed ID: 32726653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of opioid analgesic tolerance in rat to extended-release buprenorphine formulated for laboratory subjects.
    Larson CM; Barajas C; Kitto KF; Wilcox GL; Fairbanks CA; Peterson CD
    PLoS One; 2024; 19(3):e0298819. PubMed ID: 38512918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
    Pick CG; Peter Y; Schreiber S; Weizman R
    Brain Res; 1997 Jan; 744(1):41-6. PubMed ID: 9030411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of multimodal analgesic treatment of severe traumatic acute pain in mice pretreated with chronic high dose of buprenorphine inducing mechanical allodynia.
    Coutens B; Derreumaux C; Labaste F; Minville V; Guiard BP; Moulédous L; Bounes V; Roussin A; Frances B
    Eur J Pharmacol; 2020 May; 875():172884. PubMed ID: 31870829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects.
    La Vincente SF; White JM; Somogyi AA; Bochner F; Chapleo CB
    Clin Pharmacol Ther; 2008 Jan; 83(1):144-52. PubMed ID: 17568402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone.
    Glover EM; Davis M
    Psychopharmacology (Berl); 2008 Jun; 198(2):167-80. PubMed ID: 18324390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia.
    Crain SM; Shen KF
    Brain Res; 2001 Jan; 888(1):75-82. PubMed ID: 11146054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine-induced hyperalgesia in the rat.
    Wala EP; Holtman JR
    Eur J Pharmacol; 2011 Jan; 651(1-3):89-95. PubMed ID: 21114985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of naloxone on opioid-induced hyperalgesia and tolerance to remifentanil under sevoflurane anesthesia in rats.
    Aguado D; Abreu M; Benito J; Garcia-Fernandez J; Gómez de Segura IA
    Anesthesiology; 2013 May; 118(5):1160-9. PubMed ID: 23407105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice.
    Campillo A; Cabañero D; Romero A; García-Nogales P; Puig MM
    Eur J Pharmacol; 2011 Apr; 657(1-3):89-96. PubMed ID: 21300053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine in combination with naloxone at a ratio of 15:1 does not enhance antinociception from buprenorphine in healthy cats.
    Slingsby LS; Murrell JC; Taylor PM
    Vet J; 2012 Jun; 192(3):523-4. PubMed ID: 22030474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice.
    Zeitz KP; Malmberg AB; Gilbert H; Basbaum AI
    Pain; 2001 Dec; 94(3):245-253. PubMed ID: 11731061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive tolerance to NSAIDs in the rat formalin test is mediated by the opioid mechanism.
    Tsiklauri N; Nozadze I; Gurtskaia G; Tsagareli MG
    Pharmacol Rep; 2017 Feb; 69(1):168-175. PubMed ID: 27923161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice.
    Shinohara A; Andoh T; Saiki I; Kuraishi Y
    Eur J Pharmacol; 2018 Aug; 833():275-282. PubMed ID: 29886241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder.
    Nasser AF; Greenwald MK; Vince B; Fudala PJ; Twumasi-Ankrah P; Liu Y; Jones JP; Heidbreder C
    J Clin Psychopharmacol; 2016 Feb; 36(1):18-26. PubMed ID: 26650971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
    Schiene K; De Vry J; Tzschentke TM
    J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a sustained-release formulation of buprenorphine for analgesia in rats.
    Foley PL; Liang H; Crichlow AR
    J Am Assoc Lab Anim Sci; 2011 Mar; 50(2):198-204. PubMed ID: 21439213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.